Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Intellia Thera CS (NTLA)

19.14 -2.08 (-9.8%)

12-11 16:00

Open:

21.79

Pre. Close:

21.22

High:

22.0323

Low:

18.32

Volume:

1,434,047

Market Cap:

810M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

22.16 - 22.68

22.68 - 23.56

Low:

17.57 - 17.77

17.77 - 18.12

Close:

18.71 - 18.89

18.89 - 19.21

Technical analysis  (as of: 2017-12-11 4:50:08 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 25.31     One year: 28.03

Support:

Support1: 17.91    Support2: 14.90

Resistance:

Resistance1: 21.67    Resistance2: 24.00

Pivot:

21.21

Moving Averages:

MA(5): 20.66     MA(20): 20.85

MA(100): 21.85     MA(250): 17.17

MACD:

MACD(12,26): -0.68     Signal(12,26,9): -0.73

%K %D:

%K(14,3): 30.67     %D(3): 35.64

RSI:

RSI(14): 39.17

52-Week:

High: 33.34  Low: 10.83  Change(%): 20.0

Average Vol(K):

3-Month: 68896  10-Days 70166

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
NTLA has closed below the lower band by 4.3%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 37.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 02 Nov 2017 20:26:15 GMT
Intellia Therapeutics to Present at November Healthcare Investor Conferences

Mon, 11 Dec 2017 12:00:00 GMT
Intellia Therapeutics Announces New, Robust Genome Editing Data for Sickle ...

Tue, 01 Aug 2017 11:26:15 GMT
Intellia Therapeutics Announces Second Quarter 2017 Financial Results

Tue, 02 May 2017 11:26:15 GMT
Intellia Therapeutics Announces First Quarter 2017 Financial Results

Mon, 04 Dec 2017 22:30:06 GMT
Intellia Therapeutics Inc. (NTLA) Plunges 6.13% on December 04

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

42.34

Shares Float (M)

17.52

% Held by Insiders

37.92

% Held by Institutions

41.99

Shares Short (K)

3350

Shares Short Prior Month (K)

3660

Stock Financials

EPS

-1.550

EPS Est. Current Year

-1.780

EPS Est. Next Year

-2.060

EPS Est. Next Quarter

-0.460

Forward EPS

-1.991

Book Value (p.s.)

4.870

PEG Ratio

Profit Margin

-215.92

Operating Margin

-221.97

Return on Assets (ttm)

-12.6

Return on Equity (ttm)

-27.5

Qtrly Rev. Growth

50.3

Gross Profit (p.s.)

0.389

Sales Per Share

EBITDA (p.s.)

-1.254

Qtrly Earnings Growth

Operating Cash Flow (M)

-58.38

Levered Free Cash Flow (M)

-34.13

atoplab.com

Valuation

P/E

-12.35

P/E Growth Ratio

-0.10

P/BV

3.93

P/S

1125538304.00

P/CF

-13.88

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.